Singer, Susanne http://orcid.org/0000-0001-5784-7964
Hammerlid, Eva http://orcid.org/0000-0002-1813-108X
Tomaszewska, Iwona M. http://orcid.org/0000-0002-4118-5596
Amdal, Cecilie Delphin http://orcid.org/0000-0001-8422-8085
Bjordal, Kristin http://orcid.org/0000-0002-1914-494X
Herlofson, Bente Brokstad http://orcid.org/0000-0002-9621-9263
Santos, Marcos http://orcid.org/0000-0002-7055-4397
Silva, Joaquim Castro http://orcid.org/0000-0002-3934-9950
Mehanna, Hisham http://orcid.org/0000-0002-5544-6224
Fullerton, Amy http://orcid.org/0000-0002-4336-5523
Brannan, Christine http://orcid.org/0000-0002-7177-2396
Gonzalez, Loreto Fernandez http://orcid.org/0000-0001-5026-6438
Inhestern, Johanna http://orcid.org/0000-0003-4613-2810
Pinto, Monica http://orcid.org/0000-0002-0823-4907
Arraras, Juan I. http://orcid.org/0000-0002-4415-2570
Yarom, Noam http://orcid.org/0000-0001-9771-7857
Bonomo, Pierluigi
Baumann, Ingo
Galalae, Razvan http://orcid.org/0000-0001-8800-5460
Nicolatou-Galitis, Ourania http://orcid.org/0000-0001-9036-6329
Kiyota, Naomi http://orcid.org/0000-0001-8021-6116
Raber-Durlacher, Judith http://orcid.org/0000-0003-1500-8390
Salem, Dina http://orcid.org/0000-0001-9281-0999
Fabian, Alexander http://orcid.org/0000-0003-2415-527X
Boehm, Andreas http://orcid.org/0000-0001-9511-9167
Krejovic-Trivic, Sanja
Chie, Wei-Chu http://orcid.org/0000-0001-5584-6554
Taylor, Katherine http://orcid.org/0000-0003-0768-5789
Simon, Christian http://orcid.org/0000-0002-4156-9143
Licitra, Lisa http://orcid.org/0000-0003-0623-4118
Sherman, Allen C. http://orcid.org/0000-0001-5457-1659
,
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer (001/2014)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Accepted: 5 July 2021
First Online: 16 July 2021
Declarations
:
: CA, IA, IB, KB, AB, PB, CB, JCS, WC, JR-D, AF, LF-G, AF, RG, EH, BBH, JI, ON-G, DS, MS, AS, KT, IT, SK-T, and NY declare they have no conflicts of interest. NK reports honoraria from ONO PHARMACEUTICAL, Bristol Meyers Squibb, Merck Biopharma, Astra-Zeneca, Merck Sharp & Dohme, Eisai, Bayer and Chugai Pharmaceutical, all outside the submitted work. LL reports grants and personal fees from Astra-Zeneca, BMS, Boehringer-Ingelheim, Debiopharm International SA, Eisai, Merck-Serono, MSD, Novartis, Roche; personal fees from Bayer, Sobi, Ipsen, GSK, Doxa Pharma srl, Incyte Biosciences Italy, Amgen, Nanobiotics; grants from Celgene International, Exelicis, Hofmann-La Roche, IRX Therapeutics, Medpace, Pfizer, all outside the submitted work. HM reports grants from Cancer Research UK, during the conduct of the study; personal fees and other from Warwickshire Head Neck Clinic Ltd, personal fees from Astra-Zeneca, MSD, Sanofi Pasteur, Merck, grants from GSK Biologicals, Sanofi Pasteur, GSK PLC, Astra-Zeneca, non-financial support from Sanofi Pasteur, MSD, Merck, outside the submitted work. He is a National Institute for Health Research (NIHR) Senior Investigator. The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care. MP reports personal fees from Meeting&Words, outside the submitted work. CS reports grants from Roche, Intuitive; personal fees from Pizer, Merck, MSD, Seattle Genetics, all outside the submitted work. SS reports personal fees from Lilly, Pfizer, Boehringer-Ingelheim, all outside the submitted work.
: All sites obtained ethical approval in accordance with regional and national requirements. Approval Number from the principal investigator’s institution: 837.281.14 (9520).
: Patients were given time to consider the study and ask any questions before consenting and participating.
: All participants provided written informed consent.